Technology | February 19, 2013

Think Tank Medical Releases App for Cardiologists to Determine Patient Eligibility for Implantable Devices

Application guides doctor through a series of questions on patient medical history to evaluate eligibility for an ICD, CRT-D and CRT-P

February 19, 2013 — In response to the astounding percentage of inappropriate and non-compliant ICD, CRT-P and CRT-D device implantations each year, Think Tank Medical has developed and released its CMS ICD Application, available for the iPhone and iPad to ensure that 100 percent of patients screened meet the evidence-based criteria for implantation.

The ICD (implantable cardioverter defibrillator) guidelines published by CMS (Center for Medicare and Medicaid Services) and utilized by cardiologists, electrophysiologist, and doctors nationwide to determine a patient’s eligibility for these cardiac devices are difficult to follow, even for the most experienced physician. Therefore, it is no surprise that the National Cardiovascular Registry has determined that 22.5 percent of all ICD implantations in the United States do not comply with Medicare guidelines. Furthermore, approximately 50 percent of patients who would otherwise be qualified for an ICD do not get such a device implanted.

In an effort to improve diagnosis of cardiac patients, the CMS ICD Application serves as a tool to guide a doctor through a series of “Yes” or “No” questions on patient medical history to evaluate a patient’s eligibility or ineligibility for an ICD, CRT-D and CRT-P in a matter of minutes. With the option to place automatic reminders in the iPhone or iPad calendar, re-evaluate patients who fall into mandatory waiting periods, to send emails to the doctor and office manager to schedule follow-up appointments or send test results to the doctor and compliance officer, the process is fully automated, standardized and error-free.

Andrew Paul, founder of Think Tank Medical states, “Our primary goal with the release of this free, medical application is to get it in the hands of as many doctors as possible. Our immediate objective is to help save lives, prevent non-compliant procedures and ensure patients who need an ICD, CRT-D or CRT-P get one. We hope to aid in the transformation and progressions of today’s seemingly complex healthcare industry and revolutionize the way eligibility determinations are made, in an error free manner and change the way the industry operates on a daily basis.”

He continues: “Sudden cardiac arrest kills 250,000 people each year in the United States. The chance of surviving an SCA event is about 5 percent. We want to change that.”

The complete list of features and benefits of the CMS ICD Application can be found at www.cmsicd.com.

The CMS ICD App can be downloaded directly from iTunes by searching "CMS ICD" in iTunes.

For more information: www.thinktankmedical.com

Related Content

Medtronic AdaptivCRT Feature Associated with Improved Heart Failure Patient Survival
News | Cardiac Resynchronization Therapy Devices (CRT) | May 22, 2018
Medtronic plc announced study results showing its AdaptivCRT algorithm is associated with improved patient survival....
Medtronic Recalls CRT-Ds and ICDs Due to Manufacturing Error Preventing Electrical Shock Delivery
News | Cardiac Resynchronization Therapy Devices (CRT) | February 26, 2018
The U.S. Food and Drug Administration (FDA) announced that Medtronic is recalling certain implantable cardioverter...
Abbott Announces MR-Conditional Labeling for Quadra Assura CRT-D and Fortify Assura ICD
Technology | Cardiac Resynchronization Therapy Devices (CRT) | January 03, 2018
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT) | August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT) | July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Videos | Cardiac Resynchronization Therapy Devices (CRT) | May 23, 2017
This video, provided by ERB, demonstrates the function and implantation of the WiSE CRT (Wireless Stimulation Endocar
Biotronik Announces FDA Approval of MultiPole Pacing
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 11, 2017
May 11, 2017 — Biotronik announced U.S.
Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 10, 2017
Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardiac rhythm...
Overlay Init